DNAPrint Genomics, Inc. Product Pipeline Analysis

SUMMARY

DNAPrint Genomics, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a DNAPrint Genomics, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Financial Performance 7
2.3 Industry Outlook -- In Vitro Diagnostics 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
7 Recent Developments 12
7.1 Product News 12
7.1.1 Mar 29, 2004: DNAPrint Genomics, Inc. Forms Joint Research Program With The H. Lee Moffitt Cancer Center And Research Institute 12
7.1.2 Mar 29, 2004: DNAPrint Genomics, Inc. Forms Joint Research Program With The H. Lee Moffitt Cancer Center And Research Institute 12
8 DNAPrint Genomics, Inc. Pipeline Products 13
8.1 DNAPrint Genomics, Inc. Product Pipeline Analysis 13
8.1.1 DNAPrint Genomics, Inc. Pipeline Products By Equipment Type 13
8.1.2 DNAPrint Genomics, Inc. Pipeline Products By Development Stage 14
8.1.3 DNAPrint Genomics, Inc. Pipeline Products By Therapy Area 15
8.1.4 DNAPrint Genomics, Inc. Pipeline Products By News Summary 15
8.2 Statinome 15
8.2.1 Product Description 15
8.2.2 Product Status 16
8.3 Acenome 16
8.3.1 Product Description 16
8.3.2 Product Status 16
8.4 BC-LOH 16
8.4.1 Product Description 17
8.4.2 Product Status 17
8.5 Melphalan/Topotecan response test 17
8.5.1 Product Description 17
8.5.2 Product Status 17
8.5.3 Product Milestone 18
8.6 Xeleri/Xelox response test 18
8.6.1 Product Description 18
8.6.2 Product Status 19
8.6.3 Product Milestone 19
9 Appendix 20
9.1 Methodology 20
9.1.1 Coverage 20
9.1.2 Secondary Research 21
9.1.3 Primary Research 21
9.1.4 Expert Panel Validation 22
9.2 Contact Us 22
9.3 About Global Markets Direct 22
9.4 Disclaimer 22

1.1 List Of Tables
Table 1: DNAPrint Genomics, Inc.,Key Facts 7
Table 2: DNAPrint Genomics, Inc., Key Employees, 10
Table 3: DNAPrint Genomics, Inc. Pipeline Products by Equipment Type 13
Table 4: DNAPrint Genomics, Inc. Pipeline Products By Development Stage 14
Table 5: DNAPrint Genomics, Inc. Pipeline Products By Therapy Area 15
Table 6: DNAPrint Genomics, Inc. Pipeline Products By News Summaries 15

1.2 List of Figures
Figure 1: DNAPrint Genomics, Inc. Pipeline Products By Development Stage 14
Figure 2: Global Markets Direct Methodology 20